SUPERNUS PHARMACEUTICALS, INC. 8-K

What Happened

• Supernus Pharmaceuticals, Inc. (SUPN) filed an SEC Form 8-K on April 22, 2026 to announce that it will report its first quarter 2026 financial and business results after the market close on Tuesday, May 5, 2026.
• The company will discuss results on a conference call and webcast the same day at 4:30 p.m. ET. A press release dated April 22, 2026 is furnished as Exhibit 99.1 to the filing.

Key Details

• Filing date: April 22, 2026 (Form 8-K, Item 2.02).
• Earnings release date: After market close on Tuesday, May 5, 2026 (Q1 2026 results).
• Conference call/webcast: Tuesday, May 5, 2026 at 4:30 p.m. ET.
• Press release attached as Exhibit 99.1 to the 8-K.

Why It Matters

• The filing sets the official date and time for Supernus’ Q1 2026 earnings release and investor call, a scheduled event that can move the stock as new quarterly results and management commentary are released.
• Investors who follow Supernus should note the timing to review the release and join the webcast if they want management commentary or to ask questions; the 8-K contains no financial results or guidance itself.